VIVELLE Side Effects

6822289-1 | Blood Glucose Increased, Dehydration, Dizziness, Fluid Retention, Fungal Infection, Headache, Muscle Spasms, Overdose, Pain
on Jul 07, 2010 Female patient from UNITED STATES , 58 years of age, weighting 160.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, dehydration, dizziness (What is dizziness?), fluid retention, fungal infection (What is fungal infection?), headache (What is headache?), muscle spasms, overdose, pain (What is pain?). Vivelle dosage: 0.025 2 Twice Weekly.

6734368-8 | Anaemia, Breast Cancer, Breast Cellulitis, Breast Discharge, Breast Lump Removal, Cough, Dizziness, Erythema, Gait Disturbance
Patient was taking Vivelle (View Usage). Patient had the following side effects: anaemia, breast cancer (What is breast cancer?), breast cellulitis, breast discharge, breast lump removal, cough, dizziness (What is dizziness?), erythema, gait disturbance on Feb 11, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 145.0 lb, was diagnosed with hot flush and. Vivelle dosage: 0.05 Mg, Unk. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), ESTROPIPATE (View Estropipate Review and Estropipate Label ), OGEN (1.25 Unk, Unk) (View Ogen Review and Ogen Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), PREVACID (View Prevacid Review and Prevacid Label ), PLAQUENIL (200 Mg, Daily) (View Plaquenil Review and Plaquenil Label ). Patient was hospitalized.

6725824-7 | Accident, Back Pain, Biopsy Breast Abnormal, Biopsy Endometrium Abnormal, Bladder Disorder, Breast Calcifications, Breast Cancer, Breast Disorder, Breast Hyperplasia
Adverse event was reported on May 03, 2010 by a Female patient taking Vivelle (View Usage) (Dosage: 0.05 Mg/day, Unk) was diagnosed with menopause (What is menopause?) and. Location: UNITED STATES , weighting 157.0 lb, After Vivelle was administered, patient had the following side effects: accident, back pain (What is back pain?), biopsy breast abnormal, biopsy endometrium abnormal, bladder disorder, breast calcifications, breast cancer (What is breast cancer?), breast disorder, breast hyperplasia. During the same period patient was treated with VIVELLE DOT (0.5 Mg, Unk) (View Vivelle-dot Review and Vivelle-dot Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), MEDROXYPROGESTERONE (5 Mg, Unk) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), CLIMARA (0.05 Mg, Unk) (View Climara Review and Climara Label ), ELMIRON (100 Mg, Unk) (View Elmiron Review and Elmiron Label ).

6659837-0 | Coronary Artery Thrombosis, Muscle Strain, Myocardial Infarction, Pain, Procedural Complication
on Mar 30, 2010 Female patient from UNITED STATES , 50 years of age, weighting 111.0 lb, was diagnosed with hysterectomy (What is hysterectomy?), migraine (What is migraine?), oral contraception, transdermal contraception and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery thrombosis, muscle strain, myocardial infarction, pain (What is pain?), procedural complication. Vivelle dosage: .01 1x Week. During the same period patient was treated with MAXALT (5 1or 2 Every 2 Or 3 Weeks) (View Maxalt Review and Maxalt Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ). Patient was hospitalized.


6619751-3 | Accident, Back Pain, Biopsy Breast Abnormal, Biopsy Endometrium Abnormal, Bladder Disorder, Breast Calcifications, Breast Cancer, Breast Lump Removal, Colon Polypectomy
on Feb 25, 2010 Female patient from UNITED STATES , weighting 157.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). Patient had the following side effects: accident, back pain (What is back pain?), biopsy breast abnormal, biopsy endometrium abnormal, bladder disorder, breast calcifications, breast cancer (What is breast cancer?), breast lump removal, colon polypectomy. Vivelle dosage: 0.05 Mg/day, Unk. During the same period patient was treated with VIVELLE DOT (0.5 Mg, Unk) (View Vivelle-dot Review and Vivelle-dot Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), MEDROXYPROGESTERONE (5 Mg, Unk) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), CLIMARA (0.05 Mg, Unk) (View Climara Review and Climara Label ), ELMIRON (100 Mg, Unk) (View Elmiron Review and Elmiron Label ).

6555650-3 | Anaemia, Anxiety, Atrophy, Biopsy Breast, Breast Cancer, Breast Lump Removal, Hormone Level Abnormal, Hypercholesterolaemia, Intervertebral Disc Protrusion
Patient was taking Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: anaemia, anxiety (What is anxiety?), atrophy, biopsy breast, breast cancer (What is breast cancer?), breast lump removal, hormone level abnormal, hypercholesterolaemia, intervertebral disc protrusion on Jan 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 154.0 lb, . Vivelle dosage: 0.1mg Patch. During the same period patient was treated with AYGESTIN (Unk) (View Aygestin Review and Aygestin Label ), PREMARIN (0.9mg) (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ), CENESTIN (View Cenestin Review and Cenestin Label ), PROMETRIUM (Unk) (View Prometrium Review and Prometrium Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), LEXAPRO (20mg) (View Lexapro Review and Lexapro Label ).

6555633-3 | Anaemia, Breast Cancer, Breast Cellulitis, Breast Discharge, Breast Lump Removal, Cough, Dizziness, Erythema, Gait Disturbance
Adverse event was reported on Jan 14, 2010 by a Female patient taking Vivelle (View Usage) (Dosage: 0.05 Mg, Unk) was diagnosed with hot flush and. Location: UNITED STATES , weighting 145.0 lb, Patient experienced the following unwanted or unexpected effects: anaemia, breast cancer (What is breast cancer?), breast cellulitis, breast discharge, breast lump removal, cough, dizziness (What is dizziness?), erythema, gait disturbance. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), ESTROPIPATE (View Estropipate Review and Estropipate Label ), OGEN (1.25 Unk, Unk) (View Ogen Review and Ogen Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), PREVACID (View Prevacid Review and Prevacid Label ), PLAQUENIL (200 Mg, Daily) (View Plaquenil Review and Plaquenil Label ). Patient was hospitalized.

6544646-3 | Abdominal Pain Upper, Angina Pectoris, Arrhythmia, Biopsy Breast, Bladder Disorder, Blood Potassium Decreased, Breast Calcifications, Breast Cancer In Situ, Breast Cyst
on Jan 14, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with menopausal symptoms, prophylaxis, menopause (What is menopause?), hypertension and was treated with Vivelle (View Usage). Patient had the following side effects: abdominal pain upper, angina pectoris, arrhythmia (What is arrhythmia?), biopsy breast, bladder disorder, blood potassium decreased, breast calcifications, breast cancer in situ, breast cyst. Vivelle dosage: 0.1 Mg, Unk. During the same period patient was treated with ESTRADERM (View Estraderm Review and Estraderm Label ), PREMARIN (0.625 Mg, Qd) (View Premarin Review and Premarin Label ), PROVERA (5 Mg, Unk) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (5 Mg, Unk) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), HYDROCHLOROTHIAZIDE (25 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6544644-X | Abdominal Distension, Anxiety, Bone Pain, Breast Cancer, Breast Disorder, Breast Pain, Cardiac Murmur, Cellulitis, Deep Vein Thrombosis
on Jan 14, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: abdominal distension, anxiety (What is anxiety?), bone pain, breast cancer (What is breast cancer?), breast disorder, breast pain, cardiac murmur, cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?). Vivelle dosage: 0.05mg. During the same period patient was treated with COMBIPATCH (50/140mcg) (View Combipatch Review and Combipatch Label ), ESTRADIOL (0.5mg) (View Estradiol Review and Estradiol Label ), PROMETRIUM (100mg) (View Prometrium Review and Prometrium Label ), GYNODIOL (0.5 Mg, Unk) (View Gynodiol Review and Gynodiol Label ).

6461764-9 | Anaemia, Breast Cancer, Breast Lump Removal, Cough, Dizziness, Gait Disturbance, Hyponatraemia, Insomnia, Renal Failure Acute
Patient was taking Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, breast cancer (What is breast cancer?), breast lump removal, cough, dizziness (What is dizziness?), gait disturbance, hyponatraemia, insomnia, renal failure acute on Nov 17, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 145.0 lb, . Vivelle dosage: . During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), ESTROPIPATE (View Estropipate Review and Estropipate Label ), OGEN (View Ogen Review and Ogen Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

5920370-2 | Benign Breast Neoplasm, Breast Mass
Adverse event was reported on Oct 09, 2008 by a Female patient taking Vivelle (View Usage) (Dosage: Unk) was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Location: UNITED STATES , weighting 200.2 lb, Patient had the following side effects: benign breast neoplasm, breast mass. During the same period patient was treated with ENBREL (50 Mg, Qw) (View Enbrel Review and Enbrel Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), LORATADINE (View Loratadine Review and Loratadine Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), PSEUDOEPHEDRINE HYDROCHLORIDE (View Pseudoephedrine Hydrochloride Review and Pseudoephedrine Hydrochloride Label ).

5810946-5 | Abdominal Distension, Anxiety, Bone Pain, Breast Cancer, Breast Disorder, Breast Pain, Cardiac Murmur, Cellulitis, Deep Vein Thrombosis
on Jul 07, 2008 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: abdominal distension, anxiety (What is anxiety?), bone pain, breast cancer (What is breast cancer?), breast disorder, breast pain, cardiac murmur, cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?). Vivelle dosage: 0.05mg. During the same period patient was treated with COMBIPATCH (50/140mcg) (View Combipatch Review and Combipatch Label ), ESTRADIOL (0.5mg) (View Estradiol Review and Estradiol Label ), PROMETRIUM (100mg) (View Prometrium Review and Prometrium Label ), GYNODIOL (0.5 Mg, Unk) (View Gynodiol Review and Gynodiol Label ).

5810934-9 | Abdominal Pain Upper, Angina Pectoris, Arrhythmia, Biopsy Breast, Bladder Disorder, Blood Potassium Decreased, Breast Cancer In Situ, Breast Cyst, Breast Hyperplasia
on Jul 07, 2008 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with menopausal symptoms, prophylaxis, menopause (What is menopause?), hypertension and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, angina pectoris, arrhythmia (What is arrhythmia?), biopsy breast, bladder disorder, blood potassium decreased, breast cancer in situ, breast cyst, breast hyperplasia. Vivelle dosage: 0.1 Mg, Unk. During the same period patient was treated with ESTRADERM (View Estraderm Review and Estraderm Label ), PREMARIN (0.625 Mg, Qd) (View Premarin Review and Premarin Label ), PROVERA (5 Mg, Unk) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (5 Mg, Unk) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), HYDROCHLOROTHIAZIDE (25 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5778819-4 | Accident, Back Pain, Biopsy Breast Abnormal, Biopsy Endometrium Abnormal, Bladder Disorder, Breast Cancer, Breast Lump Removal, Colon Polypectomy, Constipation
Patient was taking Vivelle (View Usage). Patient had the following side effects: accident, back pain (What is back pain?), biopsy breast abnormal, biopsy endometrium abnormal, bladder disorder, breast cancer (What is breast cancer?), breast lump removal, colon polypectomy, constipation (What is constipation?) on Jun 16, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 157.0 lb, was diagnosed with menopause (What is menopause?) and. Vivelle dosage: 0.05 Mg/day, Unk. During the same period patient was treated with VIVELLE DOT (0.5 Mg, Unk) (View Vivelle-dot Review and Vivelle-dot Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), MEDROXYPROGESTERONE (5 Mg, Unk) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), CLIMARA (0.05 Mg, Unk) (View Climara Review and Climara Label ), ELMIRON (100 Mg, Unk) (View Elmiron Review and Elmiron Label ).

5751581-7 | Biopsy Breast Abnormal, Breast Cancer, Breast Cancer Metastatic, Breast Cosmetic Surgery, Breast Pain, Breast Reconstruction, Cataract Operation, Chest Pain
Adverse event was reported on May 19, 2008 by a Female patient taking Vivelle (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 156.0 lb, After Vivelle was administered, patient had the following side effects: biopsy breast abnormal, breast cancer (What is breast cancer?), breast cancer metastatic, breast cosmetic surgery, breast pain, breast reconstruction (What is breast reconstruction?), cataract operation, chest pain (What is chest pain?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ). Patient was hospitalized.

5699724-8 | Accident, Back Pain, Biopsy Breast Abnormal, Biopsy Endometrium Abnormal, Bladder Disorder, Breast Calcifications, Breast Cancer, Breast Lump Removal, Colon Polypectomy
on Apr 01, 2008 Female patient from UNITED STATES , 56 years of age, weighting 157.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: accident, back pain (What is back pain?), biopsy breast abnormal, biopsy endometrium abnormal, bladder disorder, breast calcifications, breast cancer (What is breast cancer?), breast lump removal, colon polypectomy. Vivelle dosage: 0.05 Mg/day, Unk. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), VIVELLE DOT (0.5 Mg, Unk) (View Vivelle-dot Review and Vivelle-dot Label ), CLIMARA (0.05 Mg, Unk) (View Climara Review and Climara Label ), ELMIRON (100 Mg, Unk) (View Elmiron Review and Elmiron Label ), VIOXX (25 Mg, Unk) (View Vioxx Review and Vioxx Label ).

5599461-4 | Abdominal Distension, Anxiety, Breast Cancer, Breast Pain, Intervertebral Disc Disorder, Lymph Node Fibrosis, Lymphoedema, Malignant Breast Lump Removal, Musculoskeletal Pain
on May 25, 2007 Female patient from UNITED STATES , 53 years of age, weighting 149.9 lb, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). Patient had the following side effects: abdominal distension, anxiety (What is anxiety?), breast cancer (What is breast cancer?), breast pain, intervertebral disc disorder, lymph node fibrosis, lymphoedema, malignant breast lump removal, musculoskeletal pain. Vivelle dosage: 0.05mg, Transdermal. During the same period patient was treated with PROMETRIUM (100mg) (View Prometrium Review and Prometrium Label ), ESTRADIOL (0.5mg) (View Estradiol Review and Estradiol Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PAXIL (View Paxil Review and Paxil Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PROZAC (View Prozac Review and Prozac Label ).

5599459-6 | Glucose Tolerance Impaired, High Density Lipoprotein Decreased, Low Density Lipoprotein Increased, Oedema Peripheral, Pain In Extremity, Thrombosis
Patient was taking Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: glucose tolerance impaired, high density lipoprotein decreased, low density lipoprotein increased, oedema peripheral, pain in extremity, thrombosis on Jun 01, 2007 from UNITED STATES Additional patient health information: Female patient , 42 years of age, weighting 224.0 lb, was diagnosed with menopausal symptoms, oophorectomy and. Vivelle dosage: 0.05mg/day, Transdermal. During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ), PREMARIN (Oral) (View Premarin Review and Premarin Label ), FEMRING (Vaginal) (View Femring Review and Femring Label ).

5599458-4 | Blood Triglycerides Increased, Breast Cancer, Breast Discharge, Breast Fibrosis, Breast Inflammation, Breast Microcalcification, Breast Necrosis, Breast Reconstruction, Cholecystectomy
Adverse event was reported on Jun 29, 2007 by a Female patient taking Vivelle (View Usage) (Dosage: Transdermal) was diagnosed with hysterectomy (What is hysterectomy?) and. Location: UNITED STATES , 58 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: blood triglycerides increased, breast cancer (What is breast cancer?), breast discharge, breast fibrosis, breast inflammation, breast microcalcification, breast necrosis, breast reconstruction (What is breast reconstruction?), cholecystectomy. During the same period patient was treated with PROVERA (10mg) (View Provera Review and Provera Label ), PREMARIN (0.625mg) (View Premarin Review and Premarin Label ), ESTRADERM (0.5mg, Topical) (View Estraderm Review and Estraderm Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

5597495-7 | Biopsy Breast Abnormal, Breast Cancer, Breast Cosmetic Surgery, Breast Pain, Breast Reconstruction, Cataract Operation, Chest Pain, Chronic Obstructive Pulmonary Disease
on Jan 16, 2008 Female patient from UNITED STATES , 53 years of age, weighting 156.0 lb, was treated with Vivelle (View Usage). Patient had the following side effects: biopsy breast abnormal, breast cancer (What is breast cancer?), breast cosmetic surgery, breast pain, breast reconstruction (What is breast reconstruction?), cataract operation, chest pain (What is chest pain?), chronic obstructive pulmonary disease. Vivelle dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ). Patient was hospitalized.

5586373-5 | Accident, Back Pain, Biopsy Breast Abnormal, Biopsy Endometrium Abnormal, Bladder Disorder, Breast Calcifications, Breast Cancer, Cystocele, Eye Laser Surgery
on Jan 07, 2008 Female patient from UNITED STATES , 56 years of age, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: accident, back pain (What is back pain?), biopsy breast abnormal, biopsy endometrium abnormal, bladder disorder, breast calcifications, breast cancer (What is breast cancer?), cystocele, eye laser surgery. Vivelle dosage: 0.05 Mg/day, Unk. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ).

5532758-2 | Aspiration Breast, Benign Lung Neoplasm, Biopsy Breast Abnormal, Biopsy Mucosa Abnormal, Breast Cancer, Breast Cancer Stage Iii, Breast Discomfort, Breast Mass, Breast Microcalcification
Patient was taking Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration breast, benign lung neoplasm, biopsy breast abnormal, biopsy mucosa abnormal, breast cancer (What is breast cancer?), breast cancer stage iii, breast discomfort, breast mass, breast microcalcification on Nov 27, 2007 from UNITED STATES Additional patient health information: Female patient , 56 years of age, . Vivelle dosage: 0.0375 Mg/day. During the same period patient was treated with PREMPHASE 14/14 (View Premphase 14/14 Review and Premphase 14/14 Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

5532021-X | Abdominal Distension, Anxiety, Bone Pain, Breast Cancer, Breast Pain, Cardiac Murmur, Intervertebral Disc Disorder, Lymph Node Fibrosis, Lymphoedema
Adverse event was reported on Nov 26, 2007 by a Female patient taking Vivelle (View Usage) (Dosage: 0.05mg) was diagnosed with menopause (What is menopause?) and. Location: UNITED STATES , 53 years of age, weighting 189.0 lb, Patient had the following side effects: abdominal distension, anxiety (What is anxiety?), bone pain, breast cancer (What is breast cancer?), breast pain, cardiac murmur, intervertebral disc disorder, lymph node fibrosis, lymphoedema. During the same period patient was treated with PROMETRIUM (100mg) (View Prometrium Review and Prometrium Label ), ESTRADIOL (0.5mg) (View Estradiol Review and Estradiol Label ), GYNODIOL (View Gynodiol Review and Gynodiol Label ), COMBIPATCH (50/140mcg) (View Combipatch Review and Combipatch Label ), PREMPRO (2.5mg) (View Prempro Review and Prempro Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PAXIL (View Paxil Review and Paxil Label ).

5506080-4 | Biopsy Breast Abnormal, Breast Cancer, Breast Mass, Depression, Haemangioma Of Liver, Knee Arthroplasty, Limb Discomfort, Lung Infiltration, Lymphadenectomy
on Oct 29, 2007 Female patient from UNITED STATES , 61 years of age, weighting 190.0 lb, was diagnosed with night sweats, amnesia, affective disorder and was treated with Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: biopsy breast abnormal, breast cancer (What is breast cancer?), breast mass, depression (What is depression?), haemangioma of liver, knee arthroplasty, limb discomfort, lung infiltration, lymphadenectomy. Vivelle dosage: . During the same period patient was treated with VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ), ESTRACE (View Estrace Review and Estrace Label ), ESTRATAB (0.625 Mg, Qd) (View Estratab Review and Estratab Label ), ESTROPIPATE (1 Mg, Unk) (View Estropipate Review and Estropipate Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (2.5 Mg, Qd) (View Provera Review and Provera Label ), FISH OIL (2000 - 3000 Mg Qd) (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

5501513-1 | Abdominal Distension, Abdominal Pain, Agranulocytosis, Anxiety Disorder, Ascites, Carbohydrate Antigen 125 Increased, Cardiac Failure Congestive, Dyspnoea, Gastrooesophageal Reflux Disease
on Oct 22, 2007 Female patient from UNITED STATES , 62 years of age, weighting 140.0 lb, was diagnosed with menopausal symptoms and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), agranulocytosis, anxiety disorder, ascites, carbohydrate antigen 125 increased, cardiac failure congestive, dyspnoea, gastrooesophageal reflux disease. Vivelle dosage: 0.05 Mg, Tiw. During the same period patient was treated with VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ), PREMPRO (View Prempro Review and Prempro Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), LEVBID (View Levbid Review and Levbid Label ), DITROPAN (View Ditropan Review and Ditropan Label ), XANAX (Unk, Prn) (View Xanax Review and Xanax Label ), ESTRADERM (0.05 Mg, Tiw) (View Estraderm Review and Estraderm Label ). Patient was hospitalized.

5494190-X | Biopsy Breast Abnormal, Breast Cancer, Breast Cosmetic Surgery, Breast Reconstruction, Cataract Operation, Chronic Obstructive Pulmonary Disease, Colonic Polyp, Colonoscopy
Patient was taking Vivelle (View Usage). Patient had the following side effects: biopsy breast abnormal, breast cancer (What is breast cancer?), breast cosmetic surgery, breast reconstruction (What is breast reconstruction?), cataract operation, chronic obstructive pulmonary disease, colonic polyp (What is colonic polyp?), colonoscopy (What is colonoscopy?) on Oct 15, 2007 from UNITED STATES Additional patient health information: Female patient , 58 years of age, . Vivelle dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ). Patient was hospitalized.

5486292-9 | Adnexa Uteri Mass, Aspiration Biopsy, Back Pain, Bone Marrow Failure, Bone Pain, Breast Abscess, Breast Cancer, Breast Cancer Recurrent, Breast Enlargement
Adverse event was reported on Oct 09, 2007 by a Female patient taking Vivelle (View Usage) (Dosage: 0.05 Mg, Unk) was diagnosed with menopause (What is menopause?) and. Location: UNITED STATES , 54 years of age, weighting 145.0 lb, After Vivelle was administered, patient had the following side effects: adnexa uteri mass, aspiration biopsy, back pain (What is back pain?), bone marrow failure, bone pain, breast abscess, breast cancer (What is breast cancer?), breast cancer recurrent, breast enlargement. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), COMBIPATCH (View Combipatch Review and Combipatch Label ), PROVERA (5 Mg, Unk) (View Provera Review and Provera Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PREMPRO (.625/2.5 Mg) (View Prempro Review and Prempro Label ), PAXIL (View Paxil Review and Paxil Label ), AMBIEN (View Ambien Review and Ambien Label ).

5404800-0 | Anaemia, Anxiety, Atrial Fibrillation, Biopsy Breast, Biopsy Breast Abnormal, Breast Cancer, Breast Cellulitis, Breast Disorder Female, Breast Mass
on Jul 27, 2007 Female patient from UNITED STATES , 55 years of age, weighting 155.0 lb, was diagnosed with menopause (What is menopause?), menopausal symptoms, hypertension, haemorrhage and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, anxiety (What is anxiety?), atrial fibrillation (What is atrial fibrillation?), biopsy breast, biopsy breast abnormal, breast cancer (What is breast cancer?), breast cellulitis, breast disorder female, breast mass. Vivelle dosage: 0.05 Mg, Unk. During the same period patient was treated with ESTRADERM (0.5 Mg) (View Estraderm Review and Estraderm Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), COZAAR (25 Mg, Qd) (View Cozaar Review and Cozaar Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), DIGOXIN (0.25 Mg, Qd) (View Digoxin Review and Digoxin Label ), CLIMARA (0.5 Mg, Unk) (View Climara Review and Climara Label ), PROVERA (2.5 Mg, Unk) (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ).

5389872-4 | Accident, Back Pain, Biopsy Breast Abnormal, Biopsy Endometrium Abnormal, Bladder Disorder, Breast Cancer, Breast Microcalcification, Cystocele
on Jul 06, 2007 Female patient from UNITED STATES , 56 years of age, was diagnosed with menopause (What is menopause?) and was treated with Vivelle (View Usage). Patient had the following side effects: accident, back pain (What is back pain?), biopsy breast abnormal, biopsy endometrium abnormal, bladder disorder, breast cancer (What is breast cancer?), breast microcalcification, cystocele. Vivelle dosage: 0.05 Mg/day, Unk. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ).

5284728-X | Breast Cancer
Patient was taking Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: breast cancer (What is breast cancer?) on Sep 08, 2006 from UNITED STATES Additional patient health information: Female patient , 58 years of age, . Vivelle dosage: Transdermal. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

5284702-3 | Breast Cancer In Situ, Mastectomy
Adverse event was reported on Mar 13, 2006 by a Female patient taking Vivelle (View Usage) (Dosage: Transdermal) was diagnosed with menopausal symptoms and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer in situ, mastectomy (What is mastectomy?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

5284700-X | Blood Pressure Increased
on Nov 29, 2005 Female patient from UNITED STATES , 50 years of age, was treated with Vivelle (View Usage). Patient had the following side effects: blood pressure increased. Vivelle dosage: 0.025 Mg/day, 2x Week, Transdermal. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ).

5278793-3 | Biopsy Breast Abnormal, Breast Cancer, Breast Mass, Depression, Haemangioma Of Liver, Knee Arthroplasty, Limb Discomfort, Lung Infiltration, Lymphadenectomy
on Mar 19, 2007 Female patient from UNITED STATES , 61 years of age, weighting 198.0 lb, was diagnosed with night sweats, amnesia, affective disorder and was treated with Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: biopsy breast abnormal, breast cancer (What is breast cancer?), breast mass, depression (What is depression?), haemangioma of liver, knee arthroplasty, limb discomfort, lung infiltration, lymphadenectomy. Vivelle dosage: . During the same period patient was treated with VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ), ESTRACE (View Estrace Review and Estrace Label ), ESTRATAB (0.625 Mg, Qd) (View Estratab Review and Estratab Label ), ESTROPIPATE (1 Mg, Unk) (View Estropipate Review and Estropipate Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (2.5 Mg, Qd) (View Provera Review and Provera Label ), FISH OIL (2000 - 3000 Mg Qd) (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

5265909-8 | Aspiration Breast, Benign Lung Neoplasm, Biopsy Breast Abnormal, Biopsy Mucosa Abnormal, Breast Cancer, Breast Cancer Female, Breast Discomfort, Cervical Stricture, Colitis
Patient was taking Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration breast, benign lung neoplasm, biopsy breast abnormal, biopsy mucosa abnormal, breast cancer (What is breast cancer?), breast cancer female, breast discomfort, cervical stricture, colitis on Mar 05, 2007 from UNITED STATES Additional patient health information: Female patient , 56 years of age, . Vivelle dosage: 0.0375 Mg/day. During the same period patient was treated with PREMPHASE 14/14 (View Premphase 14/14 Review and Premphase 14/14 Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

5265904-9 | Arthralgia, Atrial Fibrillation, Atrial Flutter, Atrial Hypertrophy, Back Pain, Biopsy Breast Abnormal, Breast Cancer Female, Breast Cancer Stage Iv, Breast Hyperplasia
Adverse event was reported on Mar 05, 2007 by a Female patient taking Vivelle (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, Patient had the following side effects: arthralgia, atrial fibrillation (What is atrial fibrillation?), atrial flutter, atrial hypertrophy, back pain (What is back pain?), biopsy breast abnormal, breast cancer female, breast cancer stage iv, breast hyperplasia. During the same period patient was treated with PREMARIN (10 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (0.625 Mg, Unk) (View Provera Review and Provera Label ), CYCRIN (View Cycrin Review and Cycrin Label ), CURRETAB (View Curretab Review and Curretab Label ), ESTRACE (View Estrace Review and Estrace Label ), MPA (View Mpa Review and Mpa Label ), ESTRATEST (View Estratest Review and Estratest Label ), PREMPRO (0.625/25 Mg, Unk) (View Prempro Review and Prempro Label ). Patient was hospitalized.

5228557-1 | Anxiety, Back Pain, Blood Pressure Increased, Dizziness, Erythema, Fall, Feeling Hot And Cold, Hormone Level Abnormal, Insomnia
on Jan 23, 2007 Female patient from UNITED STATES , 50 years of age, was treated with Vivelle (View Usage). After Vivelle was administered, patient had the following side effects: anxiety (What is anxiety?), back pain (What is back pain?), blood pressure increased, dizziness (What is dizziness?), erythema, fall (What is fall?), feeling hot and cold, hormone level abnormal, insomnia. Vivelle dosage: .

5125666-2 | Gallbladder Obstruction, Gastrointestinal Disorder, Liver Disorder, Pancreatic Carcinoma, Pulmonary Embolism
on Oct 10, 2006 Female patient from UNITED STATES , 44 years of age, weighting 211.0 lb, was diagnosed with hot flush and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: gallbladder obstruction, gastrointestinal disorder, liver disorder, pancreatic carcinoma, pulmonary embolism (What is pulmonary embolism?). Vivelle dosage: 37.5 Change Twice A Week Transdermal. Patient was hospitalized.

4869317-0 | Dermatitis Contact, Metrorrhagia
Patient was taking Vivelle (View Usage). Patient had the following side effects: dermatitis contact, metrorrhagia on Dec 28, 2005 from UNITED STATES Additional patient health information: Female patient , 25 years of age, weighting 143.0 lb, was diagnosed with hysterectomy (What is hysterectomy?) and. Vivelle dosage: .

4697873-4 | Cystitis Interstitial, Nerve Injury, Pelvic Pain
Adverse event was reported on May 25, 2005 by a Female patient taking Vivelle (View Usage) (Dosage: 0.1mg, Twice Weekly) was diagnosed with hysterectomy (What is hysterectomy?), depression (What is depression?), pain (What is pain?), hypersensitivity, micturition urgency and. Location: , 31 years of age, weighting 169.8 lb, After Vivelle was administered, patient had the following side effects: cystitis interstitial, nerve injury, pelvic pain (What is pelvic pain?). During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), FLONASE (View Flonase Review and Flonase Label ), URIMAR T (Unk, Qid) (View Urimar-t Review and Urimar-t Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), EFFEXOR (View Effexor Review and Effexor Label ).

4696871-4 | Cystitis Interstitial, Nerve Injury, Pelvic Pain
on May 25, 2005 Female patient from , 31 years of age, weighting 169.8 lb, was diagnosed with hysterectomy (What is hysterectomy?), depression (What is depression?), pain (What is pain?), hypersensitivity, micturition urgency and was treated with Vivelle (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis interstitial, nerve injury, pelvic pain (What is pelvic pain?). Vivelle dosage: 0.1mg, Twice Weekly. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), FLONASE (View Flonase Review and Flonase Label ), URIMAR T (Unk, Qid) (View Urimar-t Review and Urimar-t Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), EFFEXOR (View Effexor Review and Effexor Label ).